Chondroitin sulfate for interstitial cystitis.

Abstract

(1) Chondroitin sulfate solution 2.0% is a glycosaminoglycan (GAG) replenishment therapy instilled into the bladder of GAG-deficient patients with interstitial cystitis (IC). (2) Two non-randomized, uncontrolled pilot studies report improvements in patient-reported symptoms after the use of chondroitin sulfate for one year. Prospective, randomized, head-to-head trials are needed to assess the effectiveness of this technology compared with other IC therapies. (3) The cost and demand for this technology are low, but there could be a significant impact on clinics that administer treatment, if uptake increases.

• Authors: E Palylyk-Colwell
• Journal: Issues in emerging health technologies (Issues Emerg Health Technol) Issue 84 Pg. 1-4 (May 2006) ISSN: 1488-6316 [Print] Canada
• PMID: 16724430 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Chondroitin Sulfates

Topics

• Canada
• Chondroitin Sulfates (administration & dosage, adverse effects, economics)
• Costs and Cost Analysis
• Cystitis, Interstitial (drug therapy)
• Evidence-Based Medicine
• Female
• Humans
• Male